Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform

Accesswire September 13, 2022

Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference

Accesswire September 12, 2022

Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association

Accesswire September 6, 2022

Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors

Accesswire August 23, 2022

Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues

Accesswire August 15, 2022

Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Newsfile August 9, 2022

Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

Accesswire July 18, 2022

Zomedica Announces New Global Manufacturing & Distribution Center

Accesswire July 7, 2022

Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

Accesswire July 6, 2022

Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

Accesswire June 28, 2022

Zomedica to Participate in Panel Discussion at Animal Health Investment Forum

Accesswire June 21, 2022

Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

Accesswire June 15, 2022

Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses

Accesswire June 13, 2022

Zomedica to Present at JMP Securities Life Sciences Conference

Accesswire June 8, 2022

Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary

Accesswire June 2, 2022

Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line

Accesswire May 19, 2022

Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.

Accesswire May 18, 2022

Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

Accesswire May 16, 2022

Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues

Accesswire May 10, 2022

Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship

Accesswire May 4, 2022